placeholder image
H. C. Gerstein All authors
About
Publications While At HealthPartners
selected publications
Journal Article
  • Association of fenofibrate therapy with long-term cardiovascular risk in statin-treated patients with type 2 diabetes. 
    JAMA cardiology. 2017
  • Cognitive function and brain structure in persons with type 2 diabetes mellitus after intensive lowering of blood pressure and lipid levels: a randomized clinical trial. 
    JAMA internal medicine. 2014
  • Durable change in glycaemic control following intensive management of type 2 diabetes in the ACCORD clinical trial. 
    Diabetologia. 2014
  • Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial. 
    Diabetes care. 2014
  • Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. 
    Kidney International. 2012
  • Poor cognitive function and risk of severe hypoglycemia in type 2 diabetes: post hoc epidemiologic analysis of the ACCORD trial. 
    Diabetes care. 2012
  • Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy. 
    Lancet Neurology. 2011
  • Long-term effect of rosiglitazone and/or ramipril on the incidence of diabetes. 
    Diabetologia. 2011
  • Long-term effects of intensive glucose lowering on cardiovascular outcomes. 
    New England Journal of Medicine. 2011
  • Effects of combination lipid therapy in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of intensive blood-pressure control in type 2 diabetes mellitus. 
    New England Journal of Medicine. 2010
  • Effects of medical therapies on retinopathy progression in type 2 diabetes. 
    New England Journal of Medicine. 2010
  • The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study. 
    BMJ (Clinical research ed.). 2010
  • Effects of intensive glucose lowering in type 2 diabetes. 
    New England Journal of Medicine. 2008
  • Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial: design and methods Am J Cardiol
    2007
  • Prevention of Cardiovascular Disease in Persons with Type 2 Diabetes Mellitus: Current Knowledge and Rationale for the Action to Control Cardiovascular Risk in Diabetes (ACCORD) Trial Am J Cardiol
    2007
    • Abstract
  • Microvascular effects of intensive blood pressure control and its relation to glycaemic control in the ACCORD blood pressure trial [abstract]. 
    Diabetologia. 2011
    • presentations
    Contact
    full name
  • H. C. Gerstein
  • HC Gerstein
    • Quick Info
     
    Collaboration